Literature DB >> 25151483

Ending the global HIV/AIDS pandemic: the critical role of an HIV vaccine.

Anthony S Fauci1, Gregory K Folkers1, Hilary D Marston1.   

Abstract

While the human immunodeficiency virus (HIV)/AIDS pandemic continues, the incidence of HIV infections has fallen because of the deployment of antiretroviral drugs and multiple prevention modalities. To achieve a durable end to the pandemic, a vaccine remains essential. Recent advances in vaccinology offer new promise for an effective HIV vaccine. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  HIV prevention; HIV vaccine; human immunodeficiency virus (HIV)

Mesh：

Substances：

Year:  2014        PMID： 25151483      PMCID： PMC4157695          DOI： 10.1093/cid/ciu420

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  20 in total

1.  Ending AIDS--is an HIV vaccine necessary?

Authors:  Anthony S Fauci; Hilary D Marston
Journal:  N Engl J Med       Date:  2014-02-06       Impact factor: 91.245

2.  Male circumcision coverage, knowledge, and attitudes after 4-years of program scale-up in Rakai, Uganda.

Authors:  Xiangrong Kong; Joseph Ssekasanvu; Godfrey Kigozi; Tom Lutalo; Fred Nalugoda; David Serwadda; Maria Wawer; Ronald Gray
Journal:  AIDS Behav       Date:  2014-05

3.  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

Authors:  Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para
Journal:  J Infect Dis       Date:  2005-01-27       Impact factor: 5.226

4.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

Authors:  Punnee Pitisuttithum; Peter Gilbert; Marc Gurwith; William Heyward; Michael Martin; Fritz van Griensven; Dale Hu; Jordan W Tappero; Kachit Choopanya
Journal:  J Infect Dis       Date:  2006-11-03       Impact factor: 5.226

5.  Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.

Authors:  Chasity D Andrews; William R Spreen; Hiroshi Mohri; Lee Moss; Susan Ford; Agegnehu Gettie; Kasi Russell-Lodrigue; Rudolf P Bohm; Cecilia Cheng-Mayer; Zhi Hong; Martin Markowitz; David D Ho
Journal:  Science       Date:  2014-03-04       Impact factor: 47.728

6.  Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

Authors:  Nicole A Doria-Rose; Chaim A Schramm; Jason Gorman; Penny L Moore; Jinal N Bhiman; Brandon J DeKosky; Michael J Ernandes; Ivelin S Georgiev; Helen J Kim; Marie Pancera; Ryan P Staupe; Han R Altae-Tran; Robert T Bailer; Ema T Crooks; Albert Cupo; Aliaksandr Druz; Nigel J Garrett; Kam H Hoi; Rui Kong; Mark K Louder; Nancy S Longo; Krisha McKee; Molati Nonyane; Sijy O'Dell; Ryan S Roark; Rebecca S Rudicell; Stephen D Schmidt; Daniel J Sheward; Cinque Soto; Constantinos Kurt Wibmer; Yongping Yang; Zhenhai Zhang; James C Mullikin; James M Binley; Rogier W Sanders; Ian A Wilson; John P Moore; Andrew B Ward; George Georgiou; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris; Peter D Kwong; Lawrence Shapiro; John R Mascola
Journal:  Nature       Date:  2014-03-02       Impact factor: 49.962

7.  Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission.

Authors:  Alejandro B Balazs; Yong Ouyang; Christin M Hong; Joyce Chen; Steven M Nguyen; Dinesh S Rao; Dong Sung An; David Baltimore
Journal:  Nat Med       Date:  2014-02-09       Impact factor: 53.440

8.  Immune clearance of highly pathogenic SIV infection.

Authors:  Scott G Hansen; Michael Piatak; Abigail B Ventura; Colette M Hughes; Roxanne M Gilbride; Julia C Ford; Kelli Oswald; Rebecca Shoemaker; Yuan Li; Matthew S Lewis; Awbrey N Gilliam; Guangwu Xu; Nathan Whizin; Benjamin J Burwitz; Shannon L Planer; John M Turner; Alfred W Legasse; Michael K Axthelm; Jay A Nelson; Klaus Früh; Jonah B Sacha; Jacob D Estes; Brandon F Keele; Paul T Edlefsen; Jeffrey D Lifson; Louis J Picker
Journal:  Nature       Date:  2013-09-11       Impact factor: 49.962

9.  Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Authors:  Hasina Samji; Angela Cescon; Robert S Hogg; Sharada P Modur; Keri N Althoff; Kate Buchacz; Ann N Burchell; Mardge Cohen; Kelly A Gebo; M John Gill; Amy Justice; Gregory Kirk; Marina B Klein; P Todd Korthuis; Jeff Martin; Sonia Napravnik; Sean B Rourke; Timothy R Sterling; Michael J Silverberg; Stephen Deeks; Lisa P Jacobson; Ronald J Bosch; Mari M Kitahata; James J Goedert; Richard Moore; Stephen J Gange
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

10.  Achieving the HIV prevention impact of voluntary medical male circumcision: lessons and challenges for managing programs.

Authors:  Sema K Sgaier; Jason B Reed; Anne Thomas; Emmanuel Njeuhmeli
Journal:  PLoS Med       Date:  2014-05-06       Impact factor: 11.069
View more
  24 in total

1.  Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done.

Authors:  Marco Schito; Markus Maeurer; Peter Kim; Debra Hanna; Alimuddin Zumla
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

Review 2.  Recent developments in clinical trial designs for HIV vaccine research.

Authors:  Laura Richert; Edouard Lhomme; Catherine Fagard; Yves Lévy; Geneviève Chêne; Rodolphe Thiébaut
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response.

Authors:  James J Knox; Marcus Buggert; Lela Kardava; Kelly E Seaton; Michael A Eller; David H Canaday; Merlin L Robb; Mario A Ostrowski; Steven G Deeks; Mark K Slifka; Georgia D Tomaras; Susan Moir; M Anthony Moody; Michael R Betts
Journal:  JCI Insight       Date:  2017-04-20

4.  Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.

Authors:  Tiffany M Styles; Sailaja Gangadhara; Pradeep B J Reddy; Sakeenah Hicks; Celia C LaBranche; David C Montefiori; Cynthia A Derdeyn; Pamela A Kozlowski; Vijayakumar Velu; Rama Rao Amara
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

Review 5.  Recent update in HIV vaccine development.

Authors:  So Youn Shin
Journal:  Clin Exp Vaccine Res       Date:  2016-01-27

6.  In Vivo and in Vitro Proteome Analysis of Human Immunodeficiency Virus (HIV)-1-infected, Human CD4+ T Cells.

Authors:  Johannes Nemeth; Valentina Vongrad; Karin J Metzner; Victoria P Strouvelle; Rainer Weber; Patrick Pedrioli; Ruedi Aebersold; Huldrych F Günthard; Ben C Collins
Journal:  Mol Cell Proteomics       Date:  2017-02-21       Impact factor: 5.911

7.  Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen.

Authors:  Dorothy I Jones; Justin J Pollara; Brandi T Johnson-Weaver; Celia C LaBranche; David C Montefiori; David J Pickup; Sallie R Permar; Soman N Abraham; Massimo Maddaloni; David W Pascual; Herman F Staats
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

8.  Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.

Authors:  Smita S Iyer; Sailaja Gangadhara; Blandine Victor; Xiaoying Shen; Xuemin Chen; Rafiq Nabi; Sudhir P Kasturi; Michael J Sabula; Celia C Labranche; Pradeep B J Reddy; Georgia D Tomaras; David C Montefiori; Bernard Moss; Paul Spearman; Bali Pulendran; Pamela A Kozlowski; Rama Rao Amara
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

9.  Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.

Authors:  Isabela Silva de Castro; Shari N Gordon; Jun Liu; Massimiliano Bissa; Katherine McKinnon; Hung V Trinh; Melvin N Doster; Luca Schifanella; Namal P Liyanage; JinChao Cao; Olivia Cheng; Kathryn Foulds; Mario Roederer; Richard A Koup; Xiaoying Shen; Georgia D Tomaras; David J Venzon; Donald N Forthal; Timothy Fouts; David C Montefiori; Jim Tartaglia; Mangala Rao; Mario Ostrowski; Genoveffa Franchini; Monica Vaccari
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

10.  Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials.

Authors:  Peter B Gilbert; Michal Juraska; Allan C deCamp; Shelly Karuna; Srilatha Edupuganti; Nyaradzo Mgodi; Deborah J Donnell; Carter Bentley; Nirupama Sista; Philip Andrew; Abby Isaacs; Yunda Huang; Lily Zhang; Edmund Capparelli; Nidhi Kochar; Jing Wang; Susan H Eshleman; Kenneth H Mayer; Craig A Magaret; John Hural; James G Kublin; Glenda Gray; David C Montefiori; Margarita M Gomez; David N Burns; Julie McElrath; Julie Ledgerwood; Barney S Graham; John R Mascola; Myron Cohen; Lawrence Corey
Journal:  Stat Commun Infect Dis       Date:  2017-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.